{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T08:38:31Z","timestamp":1790930311091,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T00:00:00Z","timestamp":1644451200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T00:00:00Z","timestamp":1644451200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s10147-022-02131-x","type":"journal-article","created":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T08:02:34Z","timestamp":1644480154000},"page":"948-957","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Integrative analysis identifies activated anti-tumor immune microenvironment in lung metastasis of pancreatic cancer"],"prefix":"10.1007","volume":"27","author":[{"given":"Toshihide","family":"Sasaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Nishiwada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minako","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taichi","family":"Terai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Hokuto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuko","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Doi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6208-7661","authenticated-orcid":false,"given":"Masayuki","family":"Sho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,10]]},"reference":[{"issue":"1","key":"2131_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel RL, Miller KD, Fuchs HE et al (2021) Cancer Statistics, 2021. CA Cancer J Clin 71(1):7\u201333. https:\/\/doi.org\/10.3322\/caac.21654","journal-title":"CA Cancer J Clin"},{"key":"2131_CR2","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000002734","author":"VP Groot","year":"2018","unstructured":"Groot VP, Gemenetzis G, Blair AB et al (2018) Defining and predicting early recurrence in 957 patients with resected pancreatic ductal adenocarcinoma. Ann Surg. https:\/\/doi.org\/10.1097\/SLA.0000000000002734","journal-title":"Ann Surg"},{"issue":"11","key":"2131_CR3","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","volume":"74","author":"L Rahib","year":"2014","unstructured":"Rahib L, Smith BD, Aizenberg R et al (2014) Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Can Res 74(11):2913\u20132921. https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-0155","journal-title":"Can Res"},{"issue":"43","key":"2131_CR4","doi-asserted-by":"publisher","first-page":"4846","DOI":"10.3748\/wjg.v24.i43.4846","volume":"24","author":"A McGuigan","year":"2018","unstructured":"McGuigan A, Kelly P, Turkington RC et al (2018) Pancreatic cancer: a review of clinical diagnosis, epidemiology, treatment and outcomes. World J Gastroenterol 24(43):4846\u20134861. https:\/\/doi.org\/10.3748\/wjg.v24.i43.4846","journal-title":"World J Gastroenterol"},{"issue":"10242","key":"2131_CR5","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1016\/S0140-6736(20)30974-0","volume":"395","author":"JD Mizrahi","year":"2020","unstructured":"Mizrahi JD, Surana R, Valle JW et al (2020) Pancreatic cancer. Lancet 395(10242):2008\u20132020. https:\/\/doi.org\/10.1016\/S0140-6736(20)30974-0","journal-title":"Lancet"},{"issue":"5","key":"2131_CR6","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1097\/SLA.0000000000002234","volume":"267","author":"VP Groot","year":"2018","unstructured":"Groot VP, Rezaee N, Wu W et al (2018) Patterns, timing, and predictors of recurrence following pancreatectomy for pancreatic ductal adenocarcinoma. Ann Surg 267(5):936\u2013945. https:\/\/doi.org\/10.1097\/SLA.0000000000002234","journal-title":"Ann Surg"},{"issue":"11","key":"2131_CR7","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1001\/jamasurg.2019.3337","volume":"154","author":"RP Jones","year":"2019","unstructured":"Jones RP, Psarelli EE, Jackson R et al (2019) Patterns of recurrence after resection of pancreatic ductal adenocarcinoma: a secondary analysis of the ESPAC-4 randomized adjuvant chemotherapy trial. JAMA Surg 154(11):1038\u20131048. https:\/\/doi.org\/10.1001\/jamasurg.2019.3337","journal-title":"JAMA Surg"},{"issue":"4","key":"2131_CR8","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.pan.2016.03.016","volume":"16","author":"S Kruger","year":"2016","unstructured":"Kruger S, Haas M, Burger PJ et al (2016) Isolated pulmonary metastases define a favorable subgroup in metastatic pancreatic cancer. Pancreatology 16(4):593\u2013598. https:\/\/doi.org\/10.1016\/j.pan.2016.03.016","journal-title":"Pancreatology"},{"issue":"6","key":"2131_CR9","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1159\/000439545","volume":"32","author":"K Yamashita","year":"2015","unstructured":"Yamashita K, Miyamoto A, Hama N et al (2015) Survival impact of pulmonary metastasis as recurrence of pancreatic ductal adenocarcinoma. Dig Surg 32(6):464\u2013471. https:\/\/doi.org\/10.1159\/000439545","journal-title":"Dig Surg"},{"issue":"11","key":"2131_CR10","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1007\/s00268-017-4068-6","volume":"41","author":"B Zheng","year":"2017","unstructured":"Zheng B, Ohuchida K, Yan Z et al (2017) Primary recurrence in the lung is related to favorable prognosis in patients with pancreatic cancer and postoperative recurrence. World J Surg 41(11):2858\u20132866. https:\/\/doi.org\/10.1007\/s00268-017-4068-6","journal-title":"World J Surg"},{"issue":"10","key":"2131_CR11","doi-asserted-by":"publisher","first-page":"5573","DOI":"10.21873\/anticanres.11990","volume":"37","author":"M Yasukawa","year":"2017","unstructured":"Yasukawa M, Kawaguchi T, Kawai N et al (2017) Surgical treatment for pulmonary metastasis of pancreatic ductal adenocarcinoma: study of 12 cases. Anticancer Res 37(10):5573\u20135576. https:\/\/doi.org\/10.21873\/anticanres.11990","journal-title":"Anticancer Res"},{"issue":"9","key":"2131_CR12","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1007\/s11605-011-1605-8","volume":"15","author":"GJ Arnaoutakis","year":"2011","unstructured":"Arnaoutakis GJ, Rangachari D, Laheru DA et al (2011) Pulmonary resection for isolated pancreatic adenocarcinoma metastasis: an analysis of outcomes and survival. J Gastrointest Surg 15(9):1611\u20131617. https:\/\/doi.org\/10.1007\/s11605-011-1605-8","journal-title":"J Gastrointest Surg"},{"issue":"1","key":"2131_CR13","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13045-020-00862-w","volume":"13","author":"C Pan","year":"2020","unstructured":"Pan C, Liu H, Robins E et al (2020) Next-generation immuno-oncology agents: current momentum shifts in cancer immunotherapy. J Hematol Oncol 13(1):29. https:\/\/doi.org\/10.1186\/s13045-020-00862-w","journal-title":"J Hematol Oncol"},{"issue":"4","key":"2131_CR14","doi-asserted-by":"publisher","first-page":"439","DOI":"10.6004\/jnccn.2021.0017","volume":"19","author":"MA Tempero","year":"2021","unstructured":"Tempero MA, Malafa MP, Al-Hawary M et al (2021) Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 19(4):439\u2013457. https:\/\/doi.org\/10.6004\/jnccn.2021.0017","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"2131_CR15","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s40425-018-0479-7","volume":"6","author":"S Maleki Vareki","year":"2018","unstructured":"Maleki Vareki S (2018) High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhibitors. J Immunother Cancer 6(1):157. https:\/\/doi.org\/10.1186\/s40425-018-0479-7","journal-title":"J Immunother Cancer"},{"issue":"4","key":"2131_CR16","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.immuni.2017.04.005","volume":"46","author":"CM Lloyd","year":"2017","unstructured":"Lloyd CM, Marsland BJ (2017) Lung homeostasis: influence of age, microbes, and the immune system. Immunity 46(4):549\u2013561. https:\/\/doi.org\/10.1016\/j.immuni.2017.04.005","journal-title":"Immunity"},{"issue":"Suppl 3","key":"2131_CR17","doi-asserted-by":"publisher","first-page":"S414","DOI":"10.1245\/s10434-014-3584-y","volume":"21","author":"E Shinto","year":"2014","unstructured":"Shinto E, Hase K, Hashiguchi Y et al (2014) CD8+ and FOXP3+ tumor-infiltrating T cells before and after chemoradiotherapy for rectal cancer. Ann Surg Oncol 21(Suppl 3):S414-421. https:\/\/doi.org\/10.1245\/s10434-014-3584-y","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"2131_CR18","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1186\/s12885-021-08636-4","volume":"21","author":"MC Tavares","year":"2021","unstructured":"Tavares MC, Sampaio CD, Lima GE et al (2021) A high CD8 to FOXP3 ratio in the tumor stroma and expression of PTEN in tumor cells are associated with improved survival in non-metastatic triple-negative breast carcinoma. BMC Cancer 21(1):901. https:\/\/doi.org\/10.1186\/s12885-021-08636-4","journal-title":"BMC Cancer"},{"issue":"44","key":"2131_CR19","doi-asserted-by":"publisher","first-page":"71455","DOI":"10.18632\/oncotarget.12213","volume":"7","author":"Y Zhu","year":"2016","unstructured":"Zhu Y, Li M, Mu D et al (2016) CD8+\/FOXP3+ ratio and PD-L1 expression associated with survival in pT3N0M0 stage esophageal squamous cell cancer. Oncotarget 7(44):71455\u201371465. https:\/\/doi.org\/10.18632\/oncotarget.12213","journal-title":"Oncotarget"},{"issue":"2","key":"2131_CR20","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.pathol.2020.10.007","volume":"53","author":"EC Paver","year":"2021","unstructured":"Paver EC, Cooper WA, Colebatch AJ et al (2021) Programmed death ligand-1 (PD-L1) as a predictive marker for immunotherapy in solid tumours: a guide to immunohistochemistry implementation and interpretation. Pathology 53(2):141\u2013156. https:\/\/doi.org\/10.1016\/j.pathol.2020.10.007","journal-title":"Pathology"},{"key":"2131_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/jhbp.1025","author":"E Park","year":"2021","unstructured":"Park E, Yoo JE, Hwang HK et al (2021) Combined tumor epithelial and stromal histopathology with keratin 81 expression predicts prognosis for pancreatic ductal adenocarcinoma. J Hepatobiliary Pancreat Sci. https:\/\/doi.org\/10.1002\/jhbp.1025","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"1","key":"2131_CR22","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/s12885-019-5462-2","volume":"19","author":"TP Sandberg","year":"2019","unstructured":"Sandberg TP, Stuart M, Oosting J et al (2019) Increased expression of cancer-associated fibroblast markers at the invasive front and its association with tumor-stroma ratio in colorectal cancer. BMC Cancer 19(1):284. https:\/\/doi.org\/10.1186\/s12885-019-5462-2","journal-title":"BMC Cancer"},{"issue":"4","key":"2131_CR23","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s00428-018-2408-z","volume":"473","author":"GW van Pelt","year":"2018","unstructured":"van Pelt GW, Kjaer-Frifeldt S, van Krieken J et al (2018) Scoring the tumor-stroma ratio in colon cancer: procedure and recommendations. Virchows Arch 473(4):405\u2013412. https:\/\/doi.org\/10.1007\/s00428-018-2408-z","journal-title":"Virchows Arch"},{"issue":"4","key":"2131_CR24","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1097\/SLA.0000000000002985","volume":"271","author":"K Okadome","year":"2020","unstructured":"Okadome K, Baba Y, Yagi T et al (2020) Prognostic nutritional index, tumor-infiltrating lymphocytes, and prognosis in patients with esophageal cancer. Ann Surg 271(4):693\u2013700. https:\/\/doi.org\/10.1097\/SLA.0000000000002985","journal-title":"Ann Surg"},{"key":"2131_CR25","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.57243","author":"RL Barrett","year":"2020","unstructured":"Barrett RL, Pure E (2020) Cancer-associated fibroblasts and their influence on tumor immunity and immunotherapy. Elife. https:\/\/doi.org\/10.7554\/eLife.57243","journal-title":"Elife"},{"issue":"127","key":"2131_CR26","doi-asserted-by":"publisher","first-page":"127ra137","DOI":"10.1126\/scitranslmed.3003689","volume":"4","author":"JM Taube","year":"2012","unstructured":"Taube JM, Anders RA, Young GD et al (2012) Colocalization of inflammatory response with B7\u2013h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape. Sci Transl Med 4(127):127ra137. https:\/\/doi.org\/10.1126\/scitranslmed.3003689","journal-title":"Sci Transl Med"},{"issue":"5","key":"2131_CR27","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1111\/jdv.16016","volume":"34","author":"C Bence","year":"2020","unstructured":"Bence C, Hofman V, Chamorey E et al (2020) Association of combined PD-L1 expression and tumour-infiltrating lymphocyte features with survival and treatment outcomes in patients with metastatic melanoma. J Eur Acad Dermatol Venereol 34(5):984\u2013994. https:\/\/doi.org\/10.1111\/jdv.16016","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"7","key":"2131_CR28","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.6879","volume":"2","author":"Y Yu","year":"2019","unstructured":"Yu Y, Zeng D, Ou Q et al (2019) Association of survival and immune-related biomarkers with immunotherapy in patients with non-small cell lung cancer: a meta-analysis and individual patient-level analysis. JAMA Netw Open 2(7):e196879. https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.6879","journal-title":"JAMA Netw Open"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-022-02131-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10147-022-02131-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-022-02131-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T18:10:31Z","timestamp":1650564631000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10147-022-02131-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,10]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["2131"],"URL":"https:\/\/doi.org\/10.1007\/s10147-022-02131-x","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,10]]},"assertion":[{"value":"5 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}